OppenheimerFunds’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $52.2M | Sell |
605,768
-13,362
| -2% | -$1.15M | 0.06% | 305 |
|
2018
Q4 | $47.6M | Buy |
619,130
+17,478
| +3% | +$1.34M | 0.07% | 284 |
|
2018
Q3 | $46.5M | Buy |
601,652
+324,469
| +117% | +$25.1M | 0.05% | 353 |
|
2018
Q2 | $18.8M | Sell |
277,183
-59,760
| -18% | -$4.05M | 0.02% | 596 |
|
2018
Q1 | $24.4M | Sell |
336,943
-2,243
| -0.7% | -$162K | 0.03% | 518 |
|
2017
Q4 | $25.5M | Buy |
339,186
+11,461
| +3% | +$862K | 0.03% | 507 |
|
2017
Q3 | $25.2M | Sell |
327,725
-19,541
| -6% | -$1.5M | 0.03% | 490 |
|
2017
Q2 | $26M | Buy |
347,266
+2,478
| +0.7% | +$185K | 0.03% | 474 |
|
2017
Q1 | $22.9M | Sell |
344,788
-2,507
| -0.7% | -$167K | 0.03% | 537 |
|
2016
Q4 | $22.7M | Sell |
347,295
-60,639
| -15% | -$3.96M | 0.03% | 542 |
|
2016
Q3 | $28.9M | Sell |
407,934
-76,015
| -16% | -$5.38M | 0.04% | 476 |
|
2016
Q2 | $35.8M | Buy |
483,949
+30,554
| +7% | +$2.26M | 0.05% | 399 |
|
2016
Q1 | $29.4M | Buy |
453,395
+10,846
| +2% | +$704K | 0.04% | 442 |
|
2015
Q4 | $34.1M | Buy |
442,549
+57,931
| +15% | +$4.47M | 0.04% | 417 |
|
2015
Q3 | $31.7M | Buy |
384,618
+1,484
| +0.4% | +$122K | 0.04% | 431 |
|
2015
Q2 | $33.8M | Buy |
383,134
+11,316
| +3% | +$997K | 0.04% | 449 |
|
2015
Q1 | $32.9M | Buy |
371,818
+102,901
| +38% | +$9.09M | 0.04% | 466 |
|
2014
Q4 | $22.3M | Buy |
268,917
+340
| +0.1% | +$28.2K | 0.02% | 563 |
|
2014
Q3 | $22.7M | Buy |
268,577
+20,825
| +8% | +$1.76M | 0.02% | 535 |
|
2014
Q2 | $20.1M | Hold |
247,752
| – | – | 0.02% | 579 |
|
2014
Q1 | $18.9M | Buy |
247,752
+1,116
| +0.5% | +$85K | 0.02% | 588 |
|
2013
Q4 | $17.8M | Sell |
246,636
-12,443
| -5% | -$896K | 0.02% | 591 |
|
2013
Q3 | $17.8M | Buy |
259,079
+56,531
| +28% | +$3.89M | 0.02% | 572 |
|
2013
Q2 | $12.8M | Buy |
+202,548
| New | +$12.8M | 0.02% | 632 |
|